Drug Shortage Bills Likely Drivers Of PDUFA Add-ons
This article was originally published in The Pink Sheet Daily
Executive Summary
Rep. Burgess says there appears to be enough bipartisan support for dealing with the shortage problem that it almost certainly will be added to the reauthorizing legislation.
You may also be interested in...
Battle Lines Clear On Conflict Of Interest Policy In PDUFA Reauthorization
Commissioner Hamburg says the agency likely does not need legislation to improve its conflict of interest policy, but House members still say the system needs reform. Industry and patient advocate groups push for change, while consumer groups press FDA to stand firm.
Battle Lines Clear On Conflict Of Interest Policy In PDUFA Reauthorization
Commissioner Hamburg says the agency likely does not need legislation to improve its conflict of interest policy, but House members still say the system needs reform. Industry and patient advocate groups push for change, while consumer groups press FDA to stand firm.
Drug Shortages: Generic Industry’s Self Regulation Proposal Questioned At House Hearing
Mylan’s Heather Bresch still has questions and House members ask whether it could coexist with mandatory FDA reporting legislation.